Our initial observation of the protein expression in the poor prognostic group led us to hypothesize that CHEK, excision repair, (ERCC1 and ERCC5), and SSBP2 proteins could be predictive of CLL patient outcomes. This evidence concerns the gene ERCC1 and B-cell chronic lymphocytic leukemia.